Acadia Pharmaceuticals (ACAD) Resolves Nuplazid Patent Dispute, Boosting Market Outlook
· gurufocus.com
On October 05, 2026, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced the settlement of its patent litigation with Zydus concerning its flagship drug Nuplazi
On October 05, 2026, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) announced the settlement of its patent litigation with Zydus concerning its flagship drug Nuplazi...